Pioneers diagnostics driving precision medicine that detect and monitor chronic and cancerous diseases via advanced blood-based molecular analysis.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Aqtual leverages a proprietary cell-free DNA platform to translate cutting-edge molecular research into practical blood-based diagnostics for chronic inflammatory and cancer conditions. By analyzing epigenetic and gene-regulatory signals extracted from circulating DNA, it develops precise tests that guide disease detection and therapy response. The company is advancing its rheumatoid arthritis test from pilot to clinical validation, showcasing its mission to revolutionize disease management.
Aqtual Funding
Sign up to gain insights into Aqtual funding history, including the funding round, time period, and amount raised.
| Financing Round | Date | Amount | Price per share | Valuation |
|---|---|---|---|---|
| Round | Date | Amount | PPS | Valuation |
| Series B | Jul 10, 2025 | 31M | ||
| Series A | Oct 31, 2023 | 16M |
Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Aqtual Management Team
Investors
Genoa Ventures
Manta Ray Ventures
Yu Galaxy
BOLD Capital Partners
Bold Longevity Growth Fund
Aqtual Valuations & Financials
View real-time NPM data on Aqtual stock including daily Aqtual stock price estimates, valuation history, and historical share price information. Access Aqtual financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Aqtual pricing across six independent market signals. Looking for private company due diligence data sources on Aqtual? Get in touch to learn more.
Similar Companies
like Aqtual
Droplet Biosciences
Healthcare & Life Sciences
Turning surgical drain fluid into powerful, early molecular insights to guide personalized post-surgery cancer care.
Lyra
Healthcare & Life Sciences
Digital health startup using technology to connect companies and employees to mental health providers.
Hinge Health
Healthcare & Life Sciences
Digital clinic for back, joint, and muscle pain.
Eikon Therapeutics
Healthcare & Life Sciences
Uses revolutionary technology to discover novel treatments for life-threatening diseases.
Curology
Healthcare & Life Sciences
Offers personalized prescription skin care medications delivered directly to you.
Resilience
Healthcare & Life Sciences
Operates as technology-focused biomanufacturing company dedicated to broadening access to complex medicines.
Cerebral
Healthcare & Life Sciences
Telemedicine mental health startup, providing evidence-based therapeutic techniques and medication management.
OpenEvidence
Healthcare & Life Sciences
Empowers clinicians who seek evidence‑based insights by delivering AI‑summarized medical research at the point of care.
FAQ
We have answers
Aqtual stock does not trade on public stock exchanges. Aqtual stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Aqtual stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Aqtual Stock does not trade on public stock exchanges. In order to sell Aqtual shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Aqtual does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Aqtual share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Aqtual stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Aqtual stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Aqtual stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Aqtual is a private company and has not had an IPO. There is currently no Aqtual IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Aqtual IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
